title: Azithromycin therapy for neutrophilic airways disease: myth or magic?
authors.forename: Saad F
authors.initials: SF
authors.lastname: Idris
authors.forename: Edwin R
authors.initials: ER
authors.lastname: Chilvers
authors.forename: Charles
authors.initials: C
authors.lastname: Haworth
authors.forename: Damian
authors.initials: D
authors.lastname: McKeon
authors.forename: Alison M
authors.initials: AM
authors.lastname: Condliffe
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy* / Q000276:immunology; D016207:Cytokines / Q000187:drug effects; D006790:Host-Parasite Interactions; D006801:Humans; D007113:Immunity, Innate; D009504:Neutrophils
chemical_list: D000900:Anti-Bacterial Agents; D016207:Cytokines; D017963:Azithromycin